In recent years, a hand full of AI startup companies that managed to utilize AI/ML to discover novel targets and/or design therapeutics reached human clinical trials and received massive media attention. However, there are several similar transformative cases in big pharmaceutical companies.
Subscribe to:
Post Comments (Atom)
< + > Beyond the Science by Gary Zammit – Life Sciences Today Podcast Episode 46
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Gary Zammit, PhD,...
No comments:
Post a Comment